Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02535039Phase 2Unknown
A Phase 2 trial of methylprednisolone injection in Post-operative cognitive dysfunction (POCD), sponsored by Shengjing Hospital of China Medical University. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02535039.